← Back to Search

Group 1 (First trimester ultrasound) for Obesity

N/A
Waitlist Available
Led By Cara Buskmiller, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months from randomization
Awards & highlights

Study Summary

This trial will test how well ultrasounds work in early pregnancy, and how often they need to be repeated in obese women.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months from randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months from randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completion Rate for First Trimester Scans
Completion Rate for Second Trimester Scans
Secondary outcome measures
Completion Rate of First Trimester and Second Trimester Scans
Cost of Intervention Compared to Usual Care
Gestational Age at Delivery
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 1 (First trimester ultrasound)Experimental Treatment1 Intervention
Group II: Group 2 (Second trimester anatomy ultrasound)Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group 1 (First trimester ultrasound)
2021
N/A
~130

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,849 Total Patients Enrolled
27 Trials studying Obesity
15,278 Patients Enrolled for Obesity
Cara Buskmiller, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
182 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is access to this research still available for potential participants?

"Per clinicaltrials.gov, this medical trial is not recruiting at the moment. The study was initially shared on February 1st 2021 and last updated June 1st 2022; though current enrolment has ceased, there are 955 other trials that are presently welcoming participants."

Answered by AI

Is it possible for me to take part in this clinical study?

"This trial seeks 118 candidates with obesity between 18-50 years old. Essential qualifications include a BMI of greater than 35, consent to an additional transvaginal ultrasound if necessary, no pre-existing anomalies prior to agreement and having experienced a nonviable pregnancy before 14 weeks at either The University of Texas Professional Building, Memorial City or Bellaire/Lyndon Baines Johnson Clinics."

Answered by AI

Are there any age restrictions for participants in this experiment?

"This clinical trial is recruiting participants between the ages of 18 and 50. Separately, a total of 202 studies are being conducted for individuals under 18 years old, while 596 studies are dedicated to seniors aged 65 or above."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Recent research and studies
clinicaltrials.govStudy
Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O)
Cara Buskmiller 2021. "Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04639973.
~31 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top